Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MARSTON'S PLC Director's Dealing 2018

Sep 17, 2018

4601_dirs_2018-09-17_a3b0d95b-8f21-4e9a-b715-4c5cd804b2ab.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9511A

Marston's PLC

17 September 2018

Transaction notification

This notification is made in accordance with the EU Market Abuse Regulation.

1.

Details of PDMR / PCA (person closely associated)

(a)

Name

William Rucker

(b)

Position/status

PDMR (Chairman Designate)

(c)

Initial notification/ amendment

Initial notification

2.

Details of the issuer

(a)

Name

Marston's PLC

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the financial instrument

Ordinary shares of 7.375p each

ISIN GB00B1JQDM80

(b)

Nature of the transaction

Purchase of shares by William Rucker

(c)

Price(s) and volume(s)

Price(s) Volume(s)
£0.9995 GBP 100,000

(d)

Aggregated information

-   Aggregated volume

-   Price

N/A - single transaction

N/A - single transaction

(e)

Date of the transaction

2018-09-14

(f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHEAPNXFSSPEEF